Am J Epidemiol 2003; 158:695-704.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Longitudinal Patterns of Drug Injection Behavior in the ALIVE Study Cohort,1988–2000: Description and Determinants
1 Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
2 Department of Epidemiology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3 Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, NY.
The objective of this study was to characterize longitudinal patterns of drug injection behavior for individuals and to identify their early determinants. Participants were 1,339 injection drug users recruited into the AIDS Link to Intravenous Experience (ALIVE) Study in Baltimore, Maryland, through community outreach efforts. The study was initiated in 1988, and follow-up continued through 2000, with semiannual visits. Patterns of self-reported drug injection (yes/no) were defined for each participant, based on the number of drug-use transitions. The effect of baseline factors was assessed using multinomial logistic regression models. Over the 12-year study period, four patterns were noted: 29% of participants remained persistent drug injectors, 20% ceased injection, 14% relapsed once, and 37% had multiple transitions. Persistent injectors had the shortest follow-up and the highest mortality. For persons who changed their behavior, 3.4 years elapsed before their first cessation attempt, on average. Factors differentiating the groups included history of incarceration, young age, participation in drug treatment programs, recent overdose, and commercial sex. The observed long-term injection patterns are consistent with the view of drug addiction as a chronic disease. This view emphasizes the need for prolonged efforts to sustain cessation and to prevent adverse health and social outcomes among injection drug users.
behavior; HIV; longitudinal studies; recurrence; substance abuse, intravenous
Abbreviations: Abbreviations: AIDS, acquired immunodeficiency syndrome; ALIVE, AIDS Link to Intravenous Experience; HIV, human immunodeficiency virus.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Oviedo-Joekes, B. Nosyk, D. C Marsh, D. Guh, S. Brissette, C. Gartry, M. Krausz, A. Anis, and M. T Schechter Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: Rationale and design of the NAOMI study Clinical Trials, June 1, 2009; 6(3): 261 - 271. [Abstract] [PDF]
|
|
|
|
 |
|
 A. M. Bargagli, M. Hickman, M. Davoli, C. A. Perucci, P. Schifano, M. Buster, T. Brugal, J. Vicente, and for the COSMO European Group Drug-related mortality and its impact on adult mortality in eight European countries Eur J Public Health, April 1, 2006; 16(2): 198 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Lucas, M. Griswold, K. A. Gebo, J. Keruly, R. E. Chaisson, and R. D. Moore Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral Therapy Am. J. Epidemiol., March 1, 2006; 163(5): 412 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Termorshuizen, A. Krol, M. Prins, and E. J. C. van Ameijden Long-term Outcome of Chronic Drug Use: The Amsterdam Cohort Study among Drug Users Am. J. Epidemiol., February 1, 2005; 161(3): 271 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. De Angelis, M. Hickman, and S. Yang Estimating Long-term Trends in the Incidence and Prevalence of Opiate Use/Injecting Drug Use and the Number of Former Users: Back-Calculation Methods and Opiate Overdose Deaths Am. J. Epidemiol., November 15, 2004; 160(10): 994 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Galea, A. Nandi, and D. Vlahov The Social Epidemiology of Substance Use Epidemiol. Rev., July 1, 2004; 26(1): 36 - 52. [Full Text] [PDF]
|
|